
Full text loading...
Selenium is an essential trace element that plays a role in the regulation of the metabolism of thyroid hormones. This study was designed to evaluate the effect of selenium on the volume of thyroid nodules in euthyroid patients.
In this Randomized clinical trial, a total of 60 euthyroid patients with benign thyroid nodules (solitary or multinodular goiter) and normal serum selenium were randomly divided into the intervention and control (n=30 each) groups. The intervention group received selenium 200 μg/day while the control group received placebo for 3 months. A thyroid ultrasound was used to measure thyroid nodule volume.
Selenium supplementation (200 µg/day) retained the serum selenium levels of participants in the intervention group (P=0.251), while the control group showed a significant drop in serum selenium levels (P=0.002). Moreover, the thyroid nodule volume in the intervention group showed a significant decrease after selenium supplementation (P=0.004); however, a nonsignificant increase was observed in thyroid nodule volume in the control group (P=0.262).
Selenium supplementation may reduce benign thyroid nodule volume in euthyroid patients.
IRCT20170710035001N2.